2011 Fiscal Year Final Research Report
Development of non-viral vector for gene therapy strategy using iPS cells
Project/Area Number |
22890088
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Human genetics
|
Research Institution | Kyoto University |
Principal Investigator |
HOTTA Akitsu 京都大学, iPS細胞研究所, 特定拠点助教 (50578002)
|
Research Collaborator |
MATSUI Hideto 奈良県立医科大学, 小児科, 講師
|
Project Period (FY) |
2010 – 2011
|
Keywords | 遺伝子治療 / iPS細胞 / 遺伝子導入ベクター / 血友病A |
Research Abstract |
Aiming for developing a novel gene therapy of hemophilia A, we have developed non-viralbased gene delivery vectors that can maintain foreign gene expression for long term. We identified that new transposon vectors were able to maintain reporter gene expression in human iPS cells for up to 150 days. In addition, we report here for the first time that we can deliver the full-length Factor VIII cDNA with 7. 0 kb in size by using our transposon vectors. Our transposon vector is a promising technology for future gene therapy of severe hemophilia A.
|
-
-
[Presentation] DERIVATION OF NANOG KNOCK-IN GFP REPORTER IPS CELL LINES USING MEGANUCLEASE-INDUCED HOMOLOGOUS RECOMBINATION2012
Author(s)
Duhamel. M, Perillous. S, Epinat. JC, Cedrone. F, Englund. M, Ellerstrom. C, Hyllner. J, Hotta. A, Yamanaka. S, Balbirnie. E, Sourdive. D, Rochon. C
Organizer
ISSCR annual meeting
Place of Presentation
パシフィコ横浜
Year and Date
2012-06-14
-
-
-
-
-
-